Novel therapeutic strategy against drug-resistant bacterial sepsis in compromised hosts focusing on enhancing bactericidal activity of macrophages
Novel therapeutic strategy against drug-resistant bacterial sepsis in compromised hosts focusing on enhancing bactericidal activity of macrophages
批准号:
18H02907
负责人:
Kinoshita Manabu
金额:
$11.15万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2018
资助国家:
日本
项目状态:
已结题
起止时间:
2018-04-01 至 2021-03-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
The role of Kupffer cells in systemic anti-microbial defense
库普弗细胞在全身抗微生物防御中的作用
DOI:
10.5772/intechopen.97256
发表时间:
2021
期刊:
IntechOpen, Antimicrobial Immune Response
影响因子:
--
作者:
[Nakashima H, Nakashima M, Kinoshita M, Seki S]
通讯作者:
Seki S
DOI:
10.3390/ijms20133260
发表时间:
2019-07
期刊:
International Journal of Molecular Sciences
影响因子:
5.6
作者:
[M. Kinoshita;M. Nakashima;H. Nakashima;S. Seki]
通讯作者:
M. Kinoshita;M. Nakashima;H. Nakashima;S. Seki
DOI:
--
发表时间:
2021
期刊:
Physiology News
影响因子:
--
作者:
[Hagisawa K, Kinoshita M, Sakai H, Takeoka S]
通讯作者:
Takeoka S
DOI:
10.1111/trf.15915
发表时间:
2020-06-24
期刊:
TRANSFUSION
影响因子:
2.9
作者:
[Hagisawa, Kohsuke, Kinoshita, Manabu, Sakai, Hiromi]
通讯作者:
Sakai, Hiromi
Basic fibroblast growth factor-loaded PLGA nanosheet promotes wound healing of refractory skin lesions after burn injury
负载碱性成纤维细胞生长因子的PLGA纳米片促进烧伤后难治性皮损的伤口愈合
DOI:
--
发表时间:
2018
期刊:
影响因子:
--
作者:
[Kinshita M, Aoki S, Kiyosawa T, Fujie T, Takeoka S, Hagisawa K, Seki S]
通讯作者:
Seki S
共 9 条
Development of Radiomics for molecular diagnosis of gliomas
-
批准号:16K10778
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.0万
-
财政年份:2016
-
负责人:Kinoshita Manabu
-
依托单位:
Novel antioxidant therapy for radiation-induced injuries
-
批准号:26670569
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.33万
-
财政年份:2014
-
负责人:Kinoshita Manabu
-
依托单位:
Management against surgical stress in compromised hosts
-
批准号:25293369
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.48万
-
财政年份:2013
-
负责人:Kinoshita Manabu
-
依托单位:
海外基金